wellrank.ai
Sign In
reSET logo

reSET

First cited by AI Oct 1, 2026
reset.com ↗

Surfaced organically in AI answers about online therapy. Not yet profiled.

reSET is losing the AEO war.

Not cited in a single tracked AI answer since Oct 5, 2026, down from a peak of 17% visibility in online therapy on Oct 1, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Online therapy, daily share of AI answers mentioning reSET, through Oct 14, 2026.

0.0%

Last cited Oct 5, 2026 · peak 17% on Oct 1

By engine

Where reSET is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning reSET

ChatGPTOct 1, 2026, 11:30 UTC
Online therapy platforms vs mental health apps: what is the difference?

Short answer Online therapy platforms connect you with licensed mental-health professionals (therapists, sometimes psychiatrists) for real-time or scheduled care. They’re best when you want clinical assessment, talk therapy, ongoing treatment, or medication management. Mental-health apps are software tools (self-guided programs, meditation apps, journaling, chatbots, symptom trackers) that teach skills, provide support, or deliver short interventions. They’re best for self-help, skill practice, stress reduction, or supplementing therapy. Key differences (at-a-glance) Provider: Platforms = licensed human clinicians. Apps = automated programs, guided modules, or peer volunteers; rarely licensed clinicians. Goals: Platforms = diagnosis, psychotherapy, long-term treatment, med management. Apps = skills training, mood tracking, mindfulness, brief CBT exercises. Interaction: Platforms = live video/phone/text with a therapist. Apps = on-demand content, chatbots, push notifications. Evidence & regulation: Therapy is evidence-based and clinician-delivered. Some apps are evidence-based; a few are FDA-cleared/prescription digital therapeutics. Check research for claims. Privacy/HIPAA: Reputable therapy platforms typically follow HIPAA. Many consumer apps are not HIPAA-covered — read privacy policies. Cost: Therapy platforms usually cost more (per session or subscription). Apps are often freemium or inexpensive monthly subscriptions. Suitability: Use therapy for moderate–severe symptoms, suicidality, complex trauma, medication needs. Use apps for mild stress/anxiety, sleep issues, habit-building, or between sessions. Examples and why you might pick them Online therapy platforms BetterHelp — large network of licensed therapists, flexible messaging/video sessions, subscription model; good for general talk therapy and accessibility. Talkspace — therapy plus options for psychiatric consults; messaging-based model works if you prefer text-first care. Cerebral — includes counseling and psychiatric medication management (in countries/states where available); useful if you suspect you need medication. Amwell / MDLive — telehealth platforms that provide psychiatry and therapy alongside other medical telehealth. Pride Counseling / TeenCounseling — specialized focus (LGBTQ+ or teens), helpful if you want culturally competent care. Mental-health apps Headspace — meditation, sleep, stress reduction; high-quality guided meditations and user-friendly design. Calm — sleep and relaxation-focused programs, breathing exercises; good for insomnia and stress. Sanvello — combines CBT-based exercises, mood tracking, community; backed by studies and often recommended for mild–moderate anxiety/depression. Woebot — AI chatbot using CBT techniques for on-demand support and skills practice; useful for just-in-time coping and daily check-ins. Moodpath (now MindDoc) — mood tracking with a depression assessment and recommended resources; helps identify symptoms and track progress. 7 Cups — peer support community plus paid therapy; useful for immediate emotional support and as a low-cost supplement. Pear Therapeutics / reSET — examples of prescription digital therapeutics (for substance use and other conditions) — used under clinician supervision and regulated. How to choose Severity: If you have moderate/severe depression, suicidal thoughts, self-harm, psychosis, or need meds — seek licensed clinicians or emergency care. Platforms with psychiatry are appropriate for med needs. Goals: Want deep work and diagnosis → online therapy. Want skills, relaxation, or daily tracking → app. Evidence & safety: Look for apps with peer-reviewed studies, a clinical advisory board, or regulatory clearance. Privacy: Check whether the service is HIPAA-compliant and read the privacy policy for data use/sharing. Practical: Consider cost, availability in your region, therapist matching, session format (video vs messaging), and wait times. Hybrid approach: Many people use apps for daily practice and an online therapist for weekly sessions — this can be efficient and affordable. Quick tips If you’re unsure, start with a brief consult on an online therapy platform or a primary-care telehealth visit. They can advise whether app-based care is reasonable. For safety concerns (suicidal thoughts, self-harm, or immediate danger), contact emergency services or a crisis line right away. If you’d like, tell me: whether you’re looking for therapy or self-help, your main concerns (anxiety, depression, sleep, etc.), any preferences (video vs text, need for medication), and I can recommend 1–2 specific services that fit you.

Mentioned in position 16 of 16

Read full answer with sources →

TL;DR

reSET (reset.com) is a digital health company focused on prescription digital therapeutics, particularly for substance use disorder treatment delivered through a regulated software application. In WellRank's latest index, reSET ranks fourteenth in the online therapy category with 17% AI visibility, and the single AI mention captured in the corpus carries a neutral tone, suggesting it is recognized but not yet strongly characterized in AI-generated answers.

Company Overview

reSET is the consumer-facing identity associated with Pear Therapeutics' prescription digital therapeutic product for substance use disorder. The product is designed to be used alongside outpatient treatment programs, functioning as a software-as-a-medical-device rather than a traditional telehealth platform. The business model centers on prescription access through clinicians, distinguishing it from direct-to-consumer therapy marketplaces.

Product Features

  • reSET: an FDA-authorized prescription digital therapeutic for substance use disorder
  • reSET-O: a companion product targeting opioid use disorder, used alongside buprenorphine treatment
  • Cognitive behavioral therapy based interactive modules delivered via mobile app
  • Patient progress reporting tools accessible to treating clinicians
  • Contingency management elements to encourage treatment adherence

Target Market

reSET primarily serves adults diagnosed with substance use disorder, including alcohol, cocaine, marijuana, and stimulant use disorders, as well as opioid use disorder through reSET-O. It operates within the United States healthcare system, requiring a clinician prescription, and is intended for use within structured outpatient treatment programs.

Buyer Personas

  • An adult in an outpatient substance use disorder program whose clinician prescribes a digital therapeutic to supplement in-person sessions.
  • A behavioral health prescriber or addiction medicine specialist looking for FDA-authorized digital tools to complement pharmacotherapy.
  • A health system or treatment center administrator seeking evidence-based digital adjuncts to expand patient support between visits.
  • A health insurer or pharmacy benefit manager evaluating prescription digital therapeutics for coverage inclusion.

Funding & Performance

reSET is a product of Pear Therapeutics, which was a venture-backed company that went public via a SPAC merger. Pear Therapeutics subsequently filed for bankruptcy in early 2023; the precise disposition of the reSET product and its current ownership or operational status is not publicly disclosed with full clarity at this time.

Recent Developments

Pear Therapeutics, the developer behind reSET, faced significant financial difficulties and filed for bankruptcy protection, which raised questions about the continuity of the reSET and reSET-O products. The situation drew industry attention to the challenges of commercializing prescription digital therapeutics within existing insurance reimbursement structures. The broader PDT sector continues to grapple with coverage and reimbursement hurdles that affected Pear's trajectory.

Competitive Landscape

Within WellRank's co-mention data, reSET appears alongside Woebot, Talkspace, Sanvello, Pride Counseling, Pear Therapeutics, Moodpath, MindDoc, and TeenCounseling. Its most direct competitive parallel is Pear Therapeutics itself, given the product relationship, while Woebot and Sanvello represent the broader digital mental health and app-based therapy space it is grouped with in AI answers. Unlike general online therapy platforms such as Talkspace, reSET competes specifically in the narrower prescription digital therapeutic segment.

reSET vs the brands AI recommends alongside it

The real competitive set in Online therapy: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
reSET logo
reSETThis brand
–
0.0%
7 Cups logo
7 Cups

1 shared answers

#34
8.3%
Amwell logo
Amwell

1 shared answers

#6
33.3%
BetterHelp logo
BetterHelp

1 shared answers

#2
83.3%
Calm logo
Calm

1 shared answers

#31
8.3%

Email me when overtakes reSET

One email the day the ranks flip. Nothing else.

User Sentiment

Based on WellRank's corpus, reSET has one recorded AI mention, which is neutral in tone, with no positive or cautious signals detected. This pattern suggests AI engines are aware of the brand and reference it factually in relevant contexts, but have not accumulated enough signal to characterize it with strong endorsement or concern. Public sentiment is difficult to assess independently given the product's prescription-only model and the company's recent corporate turbulence.

Pricing

Because reSET is a prescription digital therapeutic, it is not sold directly to consumers at a published retail price. Coverage and out-of-pocket cost depend on individual insurance plans and formulary decisions; pricing is not published in a standard consumer-facing format.

Sources cited around reSET

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track reSET weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at reSET? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.